The first Fate Therapeutics trade was made in Q4 2019. Since then Cathie Wood bought shares ten more times and sold shares on three occasions. The investor completely sold their stake between Q4 2022 and Q1 2023.
Source: ra2 studio/Shutterstock Shares of Fate Therapeutics (NASDAQ: FATE ) stock are up 3% following a massive purchase by two of Cathie Wood’s exchange-tra...
InvestorPlace, over 1 year agoPositive news versus poor clinical trial results may determine the future of Fate Therapeutics.
The Motley Fool, over 2 years ago